Langerhans cell histiocytosis is a multi system disorder with a certain predilection for involving hypothalamic pituitary axis. We hereby report a 7 year old girl presenting with polyuria, polydipsia and growth retardation. The girl had a past history of pain in right hip joint and nodular region over chest. Water deprivation test confirmed the diagnosis of central diabetes inspidus. Other investigations revealed Growth hormone deficiency and central hypothyroidism. X-ray and MRI hip revealed absent right inferior pubic ramus with bone marrow biopsy confirming the diagnosis of histiocytosis. Patient was treated with nasal Arginine Vasopressin spray, subcutaneous growth hormone and oral thyroxine.
Introduction

L
angerhans' cell histiocytosis (LCH) is a rare disease with an annual incidence of 4 per million for the age range median in children above 3 years of age 1 . The granulomatous deposits consisting of specifi c langerhan's dendritic cells occur at multiple sites within the body and involve hypothalamic pituitary axis (HPA) in 5-50% cases 2 . Diabetes inspidus (DI) is the most common endocrine abnormality in 15-50% cases 3 with anterior pituitary dysfunction in 5-20% cases 4 . We hereby report a case of a girl child with histiocytosis presenting with DI and partial hypopituitarism.
The Case
A 7 year old girl presented with complaints of excessive thirst with thirst persisting during night, frequent urination including nocturia for six months. There was no associated altered mental status. Additionally she complained of lethargy, dry skin, cold intolerance and constipation. Three years before, she had a history of painful nodular chest lesion on ribs and pain in hip joints following which X-ray pelvis ( Figure 1 ) and MRI hip revealed absent right inferior pubic ramus. X ray skull revealed multiple radioluscent lesions ( Figure   2 ). Bone marrow biopsy revealed infi ltration with diff use large foamy histiocytes, large Langerhan's giant cells with abundant cytoplasm and lymphocytic aggregates and fi brosis with occasional red blood cells confi rming the diagnosis of histiocytosis (Figure 3 ). She was treated by chemotherapy for 2 months followed by radiotherapy for 2 months. 1 year later the parents noticed that she is gradually lagging behind in height from her peers and the younger sibling has surpassed her sister. Her scholastic performance was good.
She is product of nonconsanguineous marriage delivered by cesarian section at term. Antenatally mother had pregnancy induced hypertension. She had normal physical and mental milestones with adequate dietary intake (1200 K cal diet with 20 grams protein and 800 mg calcium per day). There was no history suggestive of raised intracranial tension, chronic illness or malabsorption.
On examination patient appeared well hydrated with normal vital parameters. Her height was 108 cm (< 3 rd percentile, height age-5 years 6months) as per Agarwal growth chart for Indian children with weight 23 kg (75 th percentile, weight age-9 years). Her pubertal staging was BI, PI. There was no goiter, midline or any other skeletal deformity, rash, bony pain, bony swellings over gum/ mandible, seborrhea ear discharge. Systemic examination including CNS was normal.
Investigations revealed serum sodium 138 meq/L, potassium 4.5 meq/L, chloride 140 meq/L, bicarbonate 20 meq/ L, blood urea nitrogen 18 mg/dl, creatinine-0.6 mg/dl and serum osmolality was 290 mosm/ kg. Twenty four hour urine volume was 5 litres ad urine osmolality was 220 mosm/kg. Fluid deprivation test was carried out for 4 hours with monitoring for conditions that might provide ono osmotic stimuli for vasopressin secretion (nausea, hypotension, vasovagal reaction). Also serial evaluation of body weight, cardiovascular stability, serum sodium was done. Urine osmolality in mosm/ kg at each hour were as follows, 1 st hour-230, 2 nd hour-270, 3 rd hour-280, 4 th hour-300. The test was stopped at 4 hours because the urine osmolality remained stable (3 consecutive urine sample osmolalities varied by < 30 mosm/kg) 5 . The plasma osmolality at 4 hours was 29 mosm/kg. Desmopressin (0.1mg) was given subcutaneously and urine osmolality was measured at 30, 60, 120 minutes thereafter. These values were 350, 420, 460 mosm/L respectively confi rming the diagnosis of central diabetes inspidus. X ray hand for bone age by Greulich Pyle's method was 5 year 6 months. Other laboratory parameters were cortisol-10.4 μg/dl, ACTH-20 pg/ml, T 4 -3.6 μg/dl, TSH-1.1 μIU/ml, prolactin-15 μg/ dl. Stimulated growth hormone levels following insulin (1.2 U ie 0.05 IU/Kg) was 1.5 ng/ml at 60 minutes and 2.3 ng/ml at 90 minutes. MRI brain revealed normal pituitary.
With the above mentioned picture, a diagnosis of central diabetes inspidus, partial hypopituitarism (growth hormone defi ciency and central hypothyroidism) due to histiocytosis was established. Patient was treated with subcutaneous rGH 0.3 mg/ kg/ week at night given at a frequency of 7 days/ week, thyroxine replacement 50 μg orally daily and calcium supplementation. Arginine vasopressin nasal spray in a concentration of 0.1 mg/ ml was prescribed at a dose of 1 spray 3 times daily
Discussion
Literature mentions that despite treatment nearly 20 % patients with multisystem involvement have a progressive disease course 6 . Similar was the scenario in our case, where the girl progressed to develop diabetes inspidus and partial hypopituitarism.
Stage III A of LCH leads to pituitary involvement 7 . The LCH cases with pituitary involvement reported in the literature had diabetes inspidus and most had panhypopituitarism 8 . DI is the most common endocrine abnormality encountered and in most cases it is complete. However, partial forms of DI may also occur and remit spontaneously 9 . In our patient it was complete and central in origin. Although DI may predate the diagnosis of LCH it develops most commonly at about 12 months with a range of many years from diagnosis 9 .
Anterior pituitary defi ciency in LCH is almost associated with DI 2 ; only a few cases with anterior pituitary dysfunction without DI have been reported 10 . GHD occurs in approximately 40% of aff ected children, and it has been related to histiocytic infi ltration of the hypothalamus 11 . GHD has frequently been observed as the fi rst endocrine defect in addition to DI. Others have found it only in relation to treatment with radiotherapy 12 . Similarly, thyroid hormone defi ciency can be a major component of anterior pituitary dysfunction in patients with LCH 9 . Some have described primary hypothyroidism due to LCH infi ltration of the thyroid gland 6 . ACTH defi ciency mostly presented in the context of generalized pituitary involvement; however, a case of isolated ACTH defi ciency has also been described 9 .
Our patient had GHD with central hypothyrodism with normal serum cortisol and ACTH levels. In addition abnormalities of the HPA were observed in 68% of patients with CNS lesions and in 81.5% of patients with DI (infundibular thickening, partial or complete empty sella with a lack of posterior pituitary bright spot on T1-weighted MRI sequences, or a pituitary mass lesion) 2 . A small pituitary or empty sella has also been described in cases of combined anterior and posterior pituitary insuffi ciency 9 . In our case there was no pituitary abnormalities in the MRI. Anterior pituitary dysfunction in the absence of structural changes on imaging could be attributed to microinjury leading to vascular impairment and scarring 11 . Other possible mechanisms include cytokine modulation from adjacent osseous lesions or an autoimmune eff ect 13 . Kaltsas et al have reported elevated prolactin levels in LCH patients, which was unlikely to be associated with hypogonadotropic hypogonadism 6 . Prolactin level was normal in our patient.
DI with structural changes in the HPA often heralds the involvement of other parts of the brain with more global neurological or neuropsychological sequelae, depending on the location of the involvement 2 . The signs and symptoms of nonendocrine hypothalamic (NEH) involvement range from disturbances in social behavior, appetite, and temperature regulation to abnormal sleeping patterns 2 . Kaltsas et al have found a high prevalence of NEH abnormalities in patients with DI and LCH; all were associated with anterior pituitary defi ciency and structural lesions on imaging. The most prominent abnormality was an abnormal eating pattern and obesity; fi ve patients developed morbid obesity, which was diffi cult to control 6 . Further abnormalities, such as disturbances in thermoregulation and adipsia, can make DI diffi cult to treat and complicate the overall management of these problematic cases 14 . No such abnormalities were noted in our subject.
Maghnie et al. attempted to identify predictors' of late endocrine sequelae in children with LCH and concluded that dynamic endocrine pituitary testing was not a useful predictor 11 . Neither the site of involvement nor the extent of the disease was associated with further endocrine deterioration. Therefore, it seems that only DI in association with markedly abnormal HPA imaging indicates patients with LCH at higher risk for anterior pituitary dysfunction. As DI is associated with multisystem disease in the majority of studies 9 , and progression may be greatly delayed 15 , such patients should be receiving regular and prolonged follow-up to identify such dysfunction and provide adequate replacement.
Conclusion
Endocrine abnormalities like diabetes inspidus and panhypopituitarism should be actively and periodically sought in patients with Langerhans cell histiocytosis as their recognition and management plays an important role in the treatment of this diffi cult condition.
